Showing results (1141-1150 of 1,205) with videos related to
Sort By:
Pageof 121
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]|September 18, 2025
[Preoperative short-course radiotherapy followed by chemotherapy and PD-1 inhibitor administration for locally advanced rectal cancer: the initial results of a randomized controlled clinical trial (STELLAR II)]H Y Li, H T Zhou, L C Wei, et al.JCO Precision Oncology|September 16, 2025
Clinical Utility and Prognostic Implications of Circulating Cell-Free DNA in Biliary Tract CancerDarren Cowzer, Madison Darmofal, Kenneth Seier, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2025
Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO TrialLihua E Budde, Huilai Zhang, Won-Seog Kim, et al.Nature Medicine|January 3, 2025
Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survivalAnna M Varghese, Maria A Perry, Joanne F Chou, et al.The New England Journal of Medicine|December 22, 2018
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic CancerThierry Conroy, Pascal Hammel, Mohamed Hebbar, et al.Annals of Surgical Oncology|January 18, 2025
Adjuvant Cytotoxic Chemotherapy may not be Associated with a Survival Advantage for Resected Intrahepatic CholangiocarcinomaJeremy Sharib, Kristen E Rhodin, Annie Liu, et al.Cancer Discovery|December 1, 2020
A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor-Associated Myocarditis and Supports a Mechanism-Based Therapeutic InterventionSpencer C Wei, Wouter C Meijers, Margaret L Axelrod, et al.Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2025
Histologic- and Genomic-Directed Adjuvant Therapy for Ampullary Adenocarcinoma: A Hidden Genome-Derived AnalysisBrett L Ecker, Kenneth Seier, Ankur Choubey, et al.Journal of the National Cancer Institute|October 26, 2024
Adjuvant modified FOLFIRINOX for resected pancreatic adenocarcinoma: clinical insights and genomic features from a large contemporary cohortFergus Keane, Catherine O'Connor, Drew Moss, et al.Nature Communications|December 15, 2023
Maternal dominance contributes to subgenome differentiation in allopolyploid fishesMin-Rui-Xuan Xu, Zhen-Yang Liao, Jordan R Brock, et al.Pageof 121